US 11623924
Modulators of alpha-1 antitrypsin
granted A61PA61P1/16A61P11/00
Quick answer
US patent 11623924 (Modulators of alpha-1 antitrypsin) held by Vertex Pharmaceuticals Incorporated expires Mon Apr 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Apr 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61P, A61P1/16, A61P11/00